Capricor Therapeutics

1 follower

‌

Capricor Therapeutics, Inc. (NASDAQ: CAPR) is a clinical-stage biotechnology company focused on the development of cell and exosome-based therapeutics for the treatment and prevention of serious diseases.

Industries

Biotechnology

Headquarters

Beverly Hills, United States

Employees

11-50

Links

Org chart

Linda Marbán

Chief Executive Officer

Linda Marbán

Collapse

Aj Bergmann

Chief Financial Officer

Kristi A. H. Elliott

Chief Science Officer

Mark Awadalla

Vice President Clinical Research & Development Operations

Yushi Feng

VP of Regulatory Affairs

Jonathan Tayco

Vice President Of Program Management, Operations And Quality

Joe Z.

Senior IP Counsel

Teams

+24

Research and Development

27 members

Leadership Team

3 members

Finance and Accounting

3 members

Similar companies

Calico

6 followers

Neuron23

1 follower

Ultima Genomics

3 followers

Manifold Bio

2 followers

Genentech

150 followers

Illumina

67 followers

Agilent Technologies

63 followers

Cytiva

10 followers

Avantor

10 followers

Promega

8 followers

United Therapeutics

7 followers

Explore companies